Our GSEA results revealed that the genes upregulated in IPF patients with high CCL2 expression were enriched in monocyte chemotaxis, positive regulation of chemokine production, CCR chemokine receptor binding, chemokine activity and chemokine receptor binding. This evidence concerns the gene CCL2 and idiopathic pulmonary fibrosis.